[4] [6] This relationship is bidirectional and complex, involving: Inflammatory pathways that affect both metabolic and mental health Hormonal dysregulation impacting mood and stress responses Psychosocial factors including stigma, body image concerns, and chronic disease burden Lifestyle factors such as reduced physical activity and poor sleep quality When GLP-1 medications improve glycaemic control, facilitate weight loss, and enhance overall metabolic health, patients may experience secondary improvements in psychological wellbeing
Chia CW, Odetunde JO, Kim W, Carlson OD, Ferrucci L, Egan JM (2014) GIP contributes to islet trihormonal abnormalities in type 2 diabetes
Evidence-Level Clarification: What These Data Doand Do NotShow It is critical to frame the ASCO GI 2026 findings accurately
We also know that the Federal Trade Commission (FTC) is cracking down on those who try to wrongfully extend patents
Archived from the original on 11 November 2017
Energy-efficient technology to meet both regulatory and ESG goals